Biodefense market refers to the pharmaceuticals, vaccines and antibodies applied in the treatment of a wide range of infectious diseases, whether those diseases emerge naturally or are deliberately introduced as an act of bioterrorism. Biodefense products generally defense against anthrax, smallpox, botulism, radiation/nuclear disasters and other disasters.
The global Biological Defense market was valued at US$ 1144 million in 2023 and is anticipated to reach US$ 1452.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The global biological defense market encompasses the products, technologies, and strategies aimed at detecting, protecting against, and responding to biological threats, including infectious diseases, bioterrorism, and pandemics. This market has gained significant attention and investment due to the increasing threat of biological agents and the need for effective defense and response mechanisms. Here are some key factors shaping the global biological defense market:
Emerging Infectious Diseases: The rise of emerging infectious diseases, such as Ebola, Zika, and most recently COVID-19, has heightened the awareness of the potential impact of biological threats on public health and security. This has led to increased investments in research, development, and deployment of biological defense systems.
Bioterrorism Threats: The persistent threat of bioterrorism, where intentional release of biological agents can cause harm to populations or disrupt societal systems, has necessitated the enhancement of defenses against biological attacks. Governments and organizations around the world are investing in countermeasures to mitigate the risk of bioterrorism incidents.
Technological Advancements: Advances in technology have significantly contributed to the development of more sophisticated and effective biological defense solutions. This includes rapid and accurate diagnostic tools, surveillance systems, biosensors, vaccines, therapeutics, and decontamination technologies.
Public and Private Sector Collaboration: Governments, defense agencies, and international organizations collaborate with private companies and research institutions to address biological defense challenges. Public-private partnerships play a crucial role in driving innovation and accelerating the development and deployment of biological defense solutions.
Regulatory Frameworks and Preparedness Strategies: Governments have implemented strategic plans and regulatory frameworks to enhance preparedness and response capabilities against biological threats. These frameworks focus on early detection, surveillance, risk assessment, threat intelligence, and coordination among agencies.
Global Health Security Initiatives: International organizations, such as the World Health Organization (WHO), World Organization for Animal Health (OIE), and World Customs Organization (WCO), work together to strengthen global health security and improve global coordination in preventing, detecting, and responding to biological threats.
Key players in the global biological defense market include pharmaceutical companies, biotechnology firms, diagnostic tool manufacturers, decontamination technology providers, and defense contractors. They are engaged in research, development, production, and distribution of products and solutions related to biological defense.
This report aims to provide a comprehensive presentation of the global market for Biological Defense, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biological Defense.
Report Scope
The Biological Defense market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biological Defense market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biological Defense companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
SIGA Technologies
Ichor Medical Systems
Emergent BioSolutions
Elusys Therapeutics
DynPort Vaccine Company
Altimmune
Cleveland BioLabs
Bavarian Nordic
Alnylam Pharmaceuticals
Achaogen
Alexeter Technologies
ANP Technologies
PathSensors
New Horizons Diagnostics
BBI Detection
Segment by Type
Anthrax
Small Pox
Botox
Other
Segment by Application
Military
Civilian
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biological Defense companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Biological Defense 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Anthrax
1.2.3 Small Pox
1.2.4 Botox
1.2.5 Other
1.3 麻豆原创 by Application
1.3.1 Global Biological Defense 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Military
1.3.3 Civilian
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biological Defense 麻豆原创 Perspective (2019-2030)
2.2 Biological Defense Growth Trends by Region
2.2.1 Global Biological Defense 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biological Defense Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Biological Defense Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Biological Defense 麻豆原创 Dynamics
2.3.1 Biological Defense Industry Trends
2.3.2 Biological Defense 麻豆原创 Drivers
2.3.3 Biological Defense 麻豆原创 Challenges
2.3.4 Biological Defense 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biological Defense Players by Revenue
3.1.1 Global Top Biological Defense Players by Revenue (2019-2024)
3.1.2 Global Biological Defense Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Biological Defense 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biological Defense Revenue
3.4 Global Biological Defense 麻豆原创 Concentration Ratio
3.4.1 Global Biological Defense 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biological Defense Revenue in 2023
3.5 Biological Defense Key Players Head office and Area Served
3.6 Key Players Biological Defense Product Solution and Service
3.7 Date of Enter into Biological Defense 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Biological Defense Breakdown Data by Type
4.1 Global Biological Defense Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Biological Defense Forecasted 麻豆原创 Size by Type (2025-2030)
5 Biological Defense Breakdown Data by Application
5.1 Global Biological Defense Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Biological Defense Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Biological Defense 麻豆原创 Size (2019-2030)
6.2 North America Biological Defense 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biological Defense 麻豆原创 Size by Country (2019-2024)
6.4 North America Biological Defense 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biological Defense 麻豆原创 Size (2019-2030)
7.2 Europe Biological Defense 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biological Defense 麻豆原创 Size by Country (2019-2024)
7.4 Europe Biological Defense 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biological Defense 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Biological Defense 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biological Defense 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Biological Defense 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biological Defense 麻豆原创 Size (2019-2030)
9.2 Latin America Biological Defense 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biological Defense 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Biological Defense 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biological Defense 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Biological Defense 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biological Defense 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Biological Defense 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 SIGA Technologies
11.1.1 SIGA Technologies Company Detail
11.1.2 SIGA Technologies Business Overview
11.1.3 SIGA Technologies Biological Defense Introduction
11.1.4 SIGA Technologies Revenue in Biological Defense Business (2019-2024)
11.1.5 SIGA Technologies Recent Development
11.2 Ichor Medical Systems
11.2.1 Ichor Medical Systems Company Detail
11.2.2 Ichor Medical Systems Business Overview
11.2.3 Ichor Medical Systems Biological Defense Introduction
11.2.4 Ichor Medical Systems Revenue in Biological Defense Business (2019-2024)
11.2.5 Ichor Medical Systems Recent Development
11.3 Emergent BioSolutions
11.3.1 Emergent BioSolutions Company Detail
11.3.2 Emergent BioSolutions Business Overview
11.3.3 Emergent BioSolutions Biological Defense Introduction
11.3.4 Emergent BioSolutions Revenue in Biological Defense Business (2019-2024)
11.3.5 Emergent BioSolutions Recent Development
11.4 Elusys Therapeutics
11.4.1 Elusys Therapeutics Company Detail
11.4.2 Elusys Therapeutics Business Overview
11.4.3 Elusys Therapeutics Biological Defense Introduction
11.4.4 Elusys Therapeutics Revenue in Biological Defense Business (2019-2024)
11.4.5 Elusys Therapeutics Recent Development
11.5 DynPort Vaccine Company
11.5.1 DynPort Vaccine Company Company Detail
11.5.2 DynPort Vaccine Company Business Overview
11.5.3 DynPort Vaccine Company Biological Defense Introduction
11.5.4 DynPort Vaccine Company Revenue in Biological Defense Business (2019-2024)
11.5.5 DynPort Vaccine Company Recent Development
11.6 Altimmune
11.6.1 Altimmune Company Detail
11.6.2 Altimmune Business Overview
11.6.3 Altimmune Biological Defense Introduction
11.6.4 Altimmune Revenue in Biological Defense Business (2019-2024)
11.6.5 Altimmune Recent Development
11.7 Cleveland BioLabs
11.7.1 Cleveland BioLabs Company Detail
11.7.2 Cleveland BioLabs Business Overview
11.7.3 Cleveland BioLabs Biological Defense Introduction
11.7.4 Cleveland BioLabs Revenue in Biological Defense Business (2019-2024)
11.7.5 Cleveland BioLabs Recent Development
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Company Detail
11.8.2 Bavarian Nordic Business Overview
11.8.3 Bavarian Nordic Biological Defense Introduction
11.8.4 Bavarian Nordic Revenue in Biological Defense Business (2019-2024)
11.8.5 Bavarian Nordic Recent Development
11.9 Alnylam Pharmaceuticals
11.9.1 Alnylam Pharmaceuticals Company Detail
11.9.2 Alnylam Pharmaceuticals Business Overview
11.9.3 Alnylam Pharmaceuticals Biological Defense Introduction
11.9.4 Alnylam Pharmaceuticals Revenue in Biological Defense Business (2019-2024)
11.9.5 Alnylam Pharmaceuticals Recent Development
11.10 Achaogen
11.10.1 Achaogen Company Detail
11.10.2 Achaogen Business Overview
11.10.3 Achaogen Biological Defense Introduction
11.10.4 Achaogen Revenue in Biological Defense Business (2019-2024)
11.10.5 Achaogen Recent Development
11.11 Alexeter Technologies
11.11.1 Alexeter Technologies Company Detail
11.11.2 Alexeter Technologies Business Overview
11.11.3 Alexeter Technologies Biological Defense Introduction
11.11.4 Alexeter Technologies Revenue in Biological Defense Business (2019-2024)
11.11.5 Alexeter Technologies Recent Development
11.12 ANP Technologies
11.12.1 ANP Technologies Company Detail
11.12.2 ANP Technologies Business Overview
11.12.3 ANP Technologies Biological Defense Introduction
11.12.4 ANP Technologies Revenue in Biological Defense Business (2019-2024)
11.12.5 ANP Technologies Recent Development
11.13 PathSensors
11.13.1 PathSensors Company Detail
11.13.2 PathSensors Business Overview
11.13.3 PathSensors Biological Defense Introduction
11.13.4 PathSensors Revenue in Biological Defense Business (2019-2024)
11.13.5 PathSensors Recent Development
11.14 New Horizons Diagnostics
11.14.1 New Horizons Diagnostics Company Detail
11.14.2 New Horizons Diagnostics Business Overview
11.14.3 New Horizons Diagnostics Biological Defense Introduction
11.14.4 New Horizons Diagnostics Revenue in Biological Defense Business (2019-2024)
11.14.5 New Horizons Diagnostics Recent Development
11.15 BBI Detection
11.15.1 BBI Detection Company Detail
11.15.2 BBI Detection Business Overview
11.15.3 BBI Detection Biological Defense Introduction
11.15.4 BBI Detection Revenue in Biological Defense Business (2019-2024)
11.15.5 BBI Detection Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
SIGA Technologies
Ichor Medical Systems
Emergent BioSolutions
Elusys Therapeutics
DynPort Vaccine Company
Altimmune
Cleveland BioLabs
Bavarian Nordic
Alnylam Pharmaceuticals
Achaogen
Alexeter Technologies
ANP Technologies
PathSensors
New Horizons Diagnostics
BBI Detection
听
听
*If Applicable.
